Oncology (Williston Park, N.Y.)HumansHodgkin DiseasePositron-Emission TomographyAntineoplastic Combined Chemotherapy ProtocolsNeoplasm Staging
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era.
Wael Abdulla Moh Khair Md
Published: 202510.46883/2025.25921053
Abstract
Interim fluorodeoxyglucose (FDG)-PET is currently the most used predictor of early response to treatment in advanced-stage Hodgkin lymphoma. Patients with a negative PET after 2 cycles of chemotherapy (PET2) have a better treatment outcome than their…
Preview only. Read the full abstract at the source